首页> 外文OA文献 >Clinical Significance of Serum Cytokeratin 19 Fragment in the Prediction of Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

【2h】

Clinical Significance of Serum Cytokeratin 19 Fragment in the Prediction of Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

机译：血清细胞角蛋白19片段预测晚期非小细胞肺癌患者化疗疗效和预后的临床意义

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chongan XU; Jiali LIU; Lili XING; Shu LIU;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer [J] . PangL., WangJ., JiangY., Experimental and therapeutic medicine . 2013,第2期

机译：血清细胞角蛋白19片段CYFRA 21-1的水平降低预示着非小细胞肺癌患者对化疗的客观反应
2. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival [J] . B Nisman, H Biran, N Heching, British Journal of Cancer . 2008,第1期

机译：血清细胞角蛋白19片段在晚期非小细胞肺癌中的预后作用：两个化疗周期后标志物变化与临床反应和生存率的不同衡量标准相关
3. Early and Specific Prediction of the Therapeutic Efficacy in Non-Small Cell Lung Cancer Patients by Nucleosomal DNA and Cytokeratin-19 Fragments [J] . STEFAN HOLDENRIEDER, PETRA STIEBER, JOACHIM VON PAWEL, Annals of the New York Academy of Sciences . 2006,第Sep期

机译：通过核糖体DNA和细胞角蛋白19片段对非小细胞肺癌患者疗效的早期和特异性预测
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
6. Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer [O] . LI PANG, JING WANG, YANWEN JIANG, -1

机译：血清细胞角蛋白19片段CYFRA 21-1的水平降低预示着非小细胞肺癌患者对化疗的客观反应
7. Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival [O] . Nisman, B, Biran, H, Heching, N, 2007

机译：血清细胞角蛋白19片段在晚期非小细胞肺癌中的预后作用：两个化疗周期后标志物变化与不同临床反应和生存率的相关性

Clinical Significance of Serum Cytokeratin 19 Fragment in the Prediction of Chemotherapy Efficacy and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅